Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Irinotecan Plus Cisplatin Compared With Etoposide Plus Cisplatin for Extensive Stage Small-cell Lung Cancer: a Multi-center, Randomized, Open Label Study

NCT02348450 is registered in ClinicalTrials.gov with Guangdong Association of Clinical Trials as lead sponsor.

NCT NCT02348450
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02348450 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Irinotecan Plus Cisplatin Compared With Etoposide Plus Cisplatin for Extensive Stage Small-cell Lung Cancer: a Multi-center, Randomized, Open Label Study
Lead sponsor
Guangdong Association of Clinical Trials
Phase
Phase 4
Overall status
Unknown status
Start date
February 28, 2015
Completion date
December 31, 2018
Enrollment
308 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

small cell lung cancer